Quality RO Industries Limited concluded its fifth Annual General Meeting (AGM) on September 30, 2026, with shareholders approving the reappointment of key managerial personnel and statutory auditors.

The meeting, held at the company’s registered office in Vadodara, saw the adoption of audited financial statements for FY26. The Statutory Auditors did not make any qualifications or observations in their report for the year ended March 31, 2026. Vivek Dholiya was elected as Chairman of the meeting by the directors present.

Key Resolutions Passed

Shareholders approved several ordinary and special business items during the session. The agenda included the reappointment of directors and the fixation of their remuneration, as well as the appointment of new statutory auditors.

Governance and Voting Details

The company noted that as it is listed on the BSE SME platform, it is exempt from e-voting requirements under the Companies (Management and Administration) Rules, 2014, per an MCA notification dated March 19, 2015. Consequently, voting was conducted via polling papers for members present. Only those recorded in the Register of Members or Beneficial Owners as of the cut-off date, September 23, 2026, were entitled to vote.

Special business resolutions also covered the approval of remuneration to directors exceeding overall managerial remuneration limits under Section 197 of the Companies Act, 2013. Additionally, related party transactions with Jay Ambe Trading and Jay Ambe Transport, both proprietorship firms, were approved by the members.

Quality RO Industries held its Board of Directors meeting on September 1, 2026, to approve the director's report for FY26 and schedule its fifth Annual General Meeting. The board also approved the reappointment of key management personnel and independent directors.

The company fixed September 23, 2026, as the cut-off date for determining shareholders eligible to vote at the AGM. Dilip Swarnkar & Associates was appointed as the scrutinizer for the voting process.

Director Reappointments

The board proposed the reappointment of the following directors, subject to shareholder approval:

• Vivek Dholiya as Managing Director for five years
• Damini Vivek Dholiya as Whole-Time Director for five years
• Ankit Jagdishbhai Kansara as Non-Executive Independent Director for five years
• Shirish Amrutlal Kotadia as Non-Executive Independent Director for five years

Vivek Dholiya is responsible for overall business expansion, while Damini Vivek Dholiya manages administration. Both are married to each other. Ankit Jagdishbhai Kansara brings accounting expertise, and Shirish Amrutlal Kotadia contributes engineering knowledge.

Auditor Appointment

The board appointed M/S Panchal SK & Associates, Chartered Accountants, as statutory auditors for a term of five consecutive years. The appointment is effective from September 1, 2026, and will remain valid until the conclusion of the general meeting for the financial year ending March 31, 2031.